Results 321 to 330 of about 48,847 (353)

[The pro-arrhythmia effects of anti-arrhythmia agents--theoretical and clinical aspects].

, 1992
Gerhard Steinbeck
openalex  

Some of the next articles are maybe not open access.

Related searches:

Understanding, recognizing, and managing toxicities of targeted anticancer therapies

Ca-A Cancer Journal for Clinicians, 2013
exaly  

[Hemodynamic effects of a new anti-arrhythmia agent: mexiletine].

, 1980
Tomassetti, F Fontana, M Masi, Andrea Mezzetti, G Poggiopollini, A Cuppini, Franco Cuccurullo   +6 more
openalex  

[Stepwise plan for anti-arrhythmia therapy. Sotalol: the class III anti-arrhythmia agent in the foreground. Report from the news conference: Anti-Arrhythmia Therapy. Frankfurt, 13 October 1993].

, 1994

openalex  

[Ethical problems posed by protocols of studies of anti-arrhythmia agents].

, 1981
G Nicolas
openalex  

Chronic Inflammation: A Common and Important Factor in the Pathogenesis of Neoplasia

Ca-A Cancer Journal for Clinicians, 2006
exaly  

[Lidocaine as an anti-arrhythmia agent].

Die Medizinische Welt, 1972
openaire   +1 more source

[Combination therapy with anti-arrhythmia agents].

Medizinische Klinik (Munich, Germany : 1983), 1992
B, Lüderitz, W, Jung, M, Manz
openaire   +1 more source

[Recent development of anti-arrhythmia agents and their adverse effects].

, 1991
Hirotoshi Inoue
openalex  

Lymphedema: A primer on the identification and management of a chronic condition in oncologic treatment

Ca-A Cancer Journal for Clinicians, 2009
exaly